Cargando…

Evaluation of Lipid Profiles and the Use of Omega-3 Essential Fatty Acid in Professional Football Players

BACKGROUND: Recent research showed 82% of 233 retired National Football League players under age 50 had abnormal narrowing and blockages in arteries compared to the general population of the same age. It has been suggested that early screening and intervention in this at-risk population be a priorit...

Descripción completa

Detalles Bibliográficos
Autores principales: Yates, Anthony, Norwig, John, Maroon, Joseph C., Bost, Jeffrey, Bradley, James P., Duca, Mark, Wecht, Daniel A., Grove, Ryan, Iso, Ariko, Cobb, Ingrid, Ross, Nathan, Borden, Meghan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445114/
https://www.ncbi.nlm.nih.gov/pubmed/23015851
http://dx.doi.org/10.1177/1941738108326978
_version_ 1782243769671745536
author Yates, Anthony
Norwig, John
Maroon, Joseph C.
Bost, Jeffrey
Bradley, James P.
Duca, Mark
Wecht, Daniel A.
Grove, Ryan
Iso, Ariko
Cobb, Ingrid
Ross, Nathan
Borden, Meghan
author_facet Yates, Anthony
Norwig, John
Maroon, Joseph C.
Bost, Jeffrey
Bradley, James P.
Duca, Mark
Wecht, Daniel A.
Grove, Ryan
Iso, Ariko
Cobb, Ingrid
Ross, Nathan
Borden, Meghan
author_sort Yates, Anthony
collection PubMed
description BACKGROUND: Recent research showed 82% of 233 retired National Football League players under age 50 had abnormal narrowing and blockages in arteries compared to the general population of the same age. It has been suggested that early screening and intervention in this at-risk population be a priority. HYPOTHESIS: Omega-3 essential fatty acid has been shown to improve cardiovascular lipid risk factors and should improve lipid profiles in professional football players to help reduce their recently shown accelerated risk of developing cardiovascular disease. METHODS: A total of 36 active national football players were randomly assigned to 2 groups: the first group (n = 20) was provided fish oil capsules (2200 mg of mixed docosahexaenoic acid and eicosapentaenoic acid and 360 mg of other omega-3s), and the second group (n = 16) served as controls during a 60-day trial. Vertical Auto Profile cholesterol tests directly measuring serum low-density lipoprotein, high-density lipoprotein, and other subfractions were performed. Compliance, side effects, and seafood consumption data were also collected. Baseline, midpoint, and poststudy blood work measured plasma docosahexaenoic acid and eicosapentaenoic acid. RESULTS: Treatment increased high-density lipoprotein (average percent change: +25.96, control +14.16), decreased triglycerides treatment (–8.06, control +43.98), very low-density lipoprotein treatment (–13.98, control +23.18), intermediate density lipoprotein (–27.58, control +12.07), remnant lipoproteins (–23.86, control +8.33), and very low-density lipoprotein-3 (–17.10, control +7.77). An average increase of 106.67% for docosahexaenoic acid and 365.82% for eicosapentaenoic acid compared to control was also shown. CONCLUSION: Omega-3 supplementation significantly improved the lipid profile of active players randomized to treatment. These results suggest that fish oil supplementation is an effective way to increase eicosapentaenoic acid and docosahexaenoic acid levels in plasma and should be considered as a method to improve modifiable cardiovascular risk lipid factors in professional football players. CLINICAL RELEVANCE: A prospective study examining the effects of 60 days of a highly purified fish oil supplementation in professional football players.
format Online
Article
Text
id pubmed-3445114
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-34451142012-09-26 Evaluation of Lipid Profiles and the Use of Omega-3 Essential Fatty Acid in Professional Football Players Yates, Anthony Norwig, John Maroon, Joseph C. Bost, Jeffrey Bradley, James P. Duca, Mark Wecht, Daniel A. Grove, Ryan Iso, Ariko Cobb, Ingrid Ross, Nathan Borden, Meghan Sports Health Primary Care BACKGROUND: Recent research showed 82% of 233 retired National Football League players under age 50 had abnormal narrowing and blockages in arteries compared to the general population of the same age. It has been suggested that early screening and intervention in this at-risk population be a priority. HYPOTHESIS: Omega-3 essential fatty acid has been shown to improve cardiovascular lipid risk factors and should improve lipid profiles in professional football players to help reduce their recently shown accelerated risk of developing cardiovascular disease. METHODS: A total of 36 active national football players were randomly assigned to 2 groups: the first group (n = 20) was provided fish oil capsules (2200 mg of mixed docosahexaenoic acid and eicosapentaenoic acid and 360 mg of other omega-3s), and the second group (n = 16) served as controls during a 60-day trial. Vertical Auto Profile cholesterol tests directly measuring serum low-density lipoprotein, high-density lipoprotein, and other subfractions were performed. Compliance, side effects, and seafood consumption data were also collected. Baseline, midpoint, and poststudy blood work measured plasma docosahexaenoic acid and eicosapentaenoic acid. RESULTS: Treatment increased high-density lipoprotein (average percent change: +25.96, control +14.16), decreased triglycerides treatment (–8.06, control +43.98), very low-density lipoprotein treatment (–13.98, control +23.18), intermediate density lipoprotein (–27.58, control +12.07), remnant lipoproteins (–23.86, control +8.33), and very low-density lipoprotein-3 (–17.10, control +7.77). An average increase of 106.67% for docosahexaenoic acid and 365.82% for eicosapentaenoic acid compared to control was also shown. CONCLUSION: Omega-3 supplementation significantly improved the lipid profile of active players randomized to treatment. These results suggest that fish oil supplementation is an effective way to increase eicosapentaenoic acid and docosahexaenoic acid levels in plasma and should be considered as a method to improve modifiable cardiovascular risk lipid factors in professional football players. CLINICAL RELEVANCE: A prospective study examining the effects of 60 days of a highly purified fish oil supplementation in professional football players. SAGE Publications 2009-01 /pmc/articles/PMC3445114/ /pubmed/23015851 http://dx.doi.org/10.1177/1941738108326978 Text en © 2009 American Orthopaedic Society for Sports Medicine
spellingShingle Primary Care
Yates, Anthony
Norwig, John
Maroon, Joseph C.
Bost, Jeffrey
Bradley, James P.
Duca, Mark
Wecht, Daniel A.
Grove, Ryan
Iso, Ariko
Cobb, Ingrid
Ross, Nathan
Borden, Meghan
Evaluation of Lipid Profiles and the Use of Omega-3 Essential Fatty Acid in Professional Football Players
title Evaluation of Lipid Profiles and the Use of Omega-3 Essential Fatty Acid in Professional Football Players
title_full Evaluation of Lipid Profiles and the Use of Omega-3 Essential Fatty Acid in Professional Football Players
title_fullStr Evaluation of Lipid Profiles and the Use of Omega-3 Essential Fatty Acid in Professional Football Players
title_full_unstemmed Evaluation of Lipid Profiles and the Use of Omega-3 Essential Fatty Acid in Professional Football Players
title_short Evaluation of Lipid Profiles and the Use of Omega-3 Essential Fatty Acid in Professional Football Players
title_sort evaluation of lipid profiles and the use of omega-3 essential fatty acid in professional football players
topic Primary Care
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445114/
https://www.ncbi.nlm.nih.gov/pubmed/23015851
http://dx.doi.org/10.1177/1941738108326978
work_keys_str_mv AT yatesanthony evaluationoflipidprofilesandtheuseofomega3essentialfattyacidinprofessionalfootballplayers
AT norwigjohn evaluationoflipidprofilesandtheuseofomega3essentialfattyacidinprofessionalfootballplayers
AT maroonjosephc evaluationoflipidprofilesandtheuseofomega3essentialfattyacidinprofessionalfootballplayers
AT bostjeffrey evaluationoflipidprofilesandtheuseofomega3essentialfattyacidinprofessionalfootballplayers
AT bradleyjamesp evaluationoflipidprofilesandtheuseofomega3essentialfattyacidinprofessionalfootballplayers
AT ducamark evaluationoflipidprofilesandtheuseofomega3essentialfattyacidinprofessionalfootballplayers
AT wechtdaniela evaluationoflipidprofilesandtheuseofomega3essentialfattyacidinprofessionalfootballplayers
AT groveryan evaluationoflipidprofilesandtheuseofomega3essentialfattyacidinprofessionalfootballplayers
AT isoariko evaluationoflipidprofilesandtheuseofomega3essentialfattyacidinprofessionalfootballplayers
AT cobbingrid evaluationoflipidprofilesandtheuseofomega3essentialfattyacidinprofessionalfootballplayers
AT rossnathan evaluationoflipidprofilesandtheuseofomega3essentialfattyacidinprofessionalfootballplayers
AT bordenmeghan evaluationoflipidprofilesandtheuseofomega3essentialfattyacidinprofessionalfootballplayers